La_Shipson Pharma Project Breakdown
Full breakdown of the $52.1 billion healthcare, education and housing development programme.
Download PDFNewsline
Newsline
News, announcements and insight from across the La_Shipson Group.
Insight
$52.1 BILLION DOLLAR LA_SHIPSON PHARMACEUTICAL LTD IN COLLABORATION WITH THE FEDERAL GOVERNMENT OF NIGERIA THROUGH THE NATIONAL BIOTECHNOLOGY RESEARCH AND DEVELOPMENT AGENCY (NBRDA)
National Healthcare, Education & Housing Development Initiative in Collaboration with Federal Government of Nigeria
Abuja, Nigeria – La_Shipson Pharmaceutical Ltd, in collaboration with the Federal Government of Nigeria through the National Biotechnology Research and Development Agency (NBRDA), today announced a landmark $52.1 billion dollar investment in Nigeria’s healthcare, education, and housing sectors.
The initiative, spearheaded by Hon. Moses Godia Shipi, Chief Executive Officer of La_Shipson Group, encompasses a comprehensive range of projects aimed at transforming Nigeria’s healthcare landscape and improving the quality of life for its citizens.
Key Projects
A $52.1 billion programme
- 1
$30,000,000
Pharmaceutical Manufacturing Plant in Abuja
A state-of-the-art facility designed to produce essential medicines and vaccines, enhancing Nigeria's pharmaceutical self-sufficiency.
- 2
$1,500,000,000
Quaternary Health Care Facility (1,000 Beds) in Abuja
A world-class hospital serving as a flagship referral center for the nation.
- 3
$10,800,000,000
Tertiary Health Care Facilities (500 Beds) in 36 States
Modernizing state-level healthcare with cutting-edge medical technology and specialist care.
- 4
$2,322,000,000
Secondary Health Care Facilities (250 Beds) in 774 LGAs
Strengthening local healthcare access with well-equipped hospitals.
- 5
$250,000,000
Primary Health Care (PHC) Facilities in all Wards
Revitalizing community healthcare with modern PHCs.
- 6
$36,000,000,000
Facility Research Institutions in all Zones
Establishing world-class research hubs for biotechnology, medical research, and innovation.
- 7
$1,000,000,000
Commercial Bank
Supporting economic growth and financial inclusion.
- 8
$10,000,000
National Micro Finance Bank
Empowering SMEs and individuals with accessible finance.
- 9
$10,000,000
Health Insurance Company
Expanding healthcare access through affordable insurance.
- 10
$150,000,000
15,000 Low-Cost Housing Units
Addressing housing needs for healthcare workers and citizens.
“This initiative is a testament to our commitment to Nigeria’s development. We are proud to partner with the Federal Government to deliver world-class healthcare, education, and housing infrastructure that will transform lives and drive economic growth.”
The project is expected to create thousands of jobs, stimulate economic activity, and position Nigeria as a hub for healthcare and biotech innovation in Africa.
Documents
La_Shipson Pharma Project Breakdown
Latest News
Strategic Partnership
La_Shipson Pharmaceutical Ltd Holds Strategic Partnership Meeting with Consiliaris Digital Systems for a Possible Collaboration to Drive Affordable Healthcare Data Across Africa
Nigeria | 13th August 2026
Nigeria – La_Shipson Pharmaceutical Ltd, a leading indigenous healthcare and research company, held a strategic partnership meeting with Consiliaris Digital Systems on Thursday, 13th August 2026.
The meeting centered on establishing an affordable, accessible healthcare data system across Africa, with the goal of positioning Consiliaris as the leading platform for population health management on the continent.
This collaboration aligns with La_Shipson’s mandate in Healthcare, Education, Housing and Finance, and supports national efforts to digitize health records, improve patient outcomes, and strengthen public health infrastructure across Nigeria’s 36 states.
Key Objectives of the Partnership
- Deploy a unified population health management platform to enable real-time data capture and analysis across hospitals and PHCs.
- Increase access to affordable digital healthcare for underserved communities in Africa.
- Integrate with the proposed hospitals network to enable seamless EMR, telemedicine, and research data sharing.
- Support government and donor health programs with reliable, secure, and compliant health data infrastructure.
La_Shipson Pharmaceutical Ltd Team
- Hon. Moses Godia Shipi - Chief Executive Officer (CEO)
- Mr. Handsome Jimoh Momoh - Board Chairman
- Barr. Ayomide Olatunde Zion - Company Secretary
- Mr. Rakesh Ghosh - Foreign Expert
- Ms. Anne Mah - Partner
Consiliaris Digital Systems Team
- Cedi Fredrick - Chief Executive Officer
- Ed Clinkett - Chief Product Technology Officer
- Josefina Chirindza - Director of Partnership & Business Development
“This partnership with Consiliaris is a critical step toward building a data-driven healthcare ecosystem in Africa. By combining La_Shipson’s healthcare delivery infrastructure with Consiliaris’ digital expertise, we will make quality healthcare data accessible and affordable for millions of Africans.”
About La_Shipson Pharmaceutical Ltd
La_Shipson Pharmaceutical Ltd is a Nigerian healthcare, research, and infrastructure company committed to improving access to quality healthcare, education, housing and financial services across Africa.
About Consiliaris Digital Systems
Consiliaris Digital Systems is a health-tech company focused on building affordable, scalable digital platforms for population health management and healthcare data interoperability across emerging markets.
Introducing Seeyoo 2026
Learn more about the Seeyoo healthcare data platform and the partnership between La_Shipson Pharmaceutical Ltd and Consiliaris Digital Systems.
Download PDF